vTv Therapeutics VTVT
NASDAQ VTVT
$21.00 -0.18 (-0.85%)
At close: Nov 10, 2026 · 4:00 PM EST

vTv Therapeutics (VTVT) Debt Ratio (2014 - 2025)

Updated

vTv Therapeutics' Debt Ratio came in at 0.00 for Q3 2025.

Analysis

vTv Therapeutics (VTVT) Debt Ratio (2014 - 2025) Analysis & Trends

For FY2023, vTv Therapeutics' Debt Ratio was 0.02, up 157.2% from FY2022.

  • Going back by year, Debt Ratio was 0.01 in FY2022 (-32.9%), 0.01 in FY2021 (+76.9%), 0.01 in FY2020 (-99.1%) and 0.67 in FY2019 (-63.7%).
  • The Q3 2025 figure represents the highest quarterly Debt Ratio in data going back to Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 0.33
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.23
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 0.55
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 0.41
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 0.08
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 0.28
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 0.56
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 0.51
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 0.31
10 vTv Therapeutics 271.03 Mn -79.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 0.00
Dec 31, 2023 0.02
Sep 30, 2023 0.03
Dec 31, 2022 0.01
Sep 30, 2022 0.02
Dec 31, 2021 0.01
Sep 30, 2021 0.02
Dec 31, 2020 0.01
Sep 30, 2020 0.34
Jun 30, 2020 0.43
Mar 31, 2020 0.60
Dec 31, 2019 0.67
Sep 30, 2019 0.97
Jun 30, 2019 1.19
Mar 31, 2019 1.23
Dec 31, 2018 1.84
Sep 30, 2018 1.64
Jun 30, 2018 1.70
Mar 31, 2018 1.35
Dec 31, 2017 0.70
API Access

vTv Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=VTVT&period=max&api_key=YOUR_API_KEY